Henipavirus Encephalitis: Recent Developments and Advances.

Kien Chai Ong, Kum Thong Wong
Author Information
  1. Kien Chai Ong: Department of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  2. Kum Thong Wong: Department ofPathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Abstract

The genus Henipavirus within the family Paramyxoviridae includes the Hendra virus (HeV) and Nipah virus (NiV) which were discovered in the 1990s in Australia and Malaysia, respectively, after emerging to cause severe and often fatal outbreaks in humans and animals. While HeV is confined to Australia, more recent NiV outbreaks have been reported in Bangladesh, India and the Philippines. The clinical manifestations of both henipaviruses in humans appear similar, with a predominance of an acute encephalitic syndrome. Likewise, the pathological features are similar and characterized by disseminated, multi-organ vasculopathy comprising endothelial infection/ulceration, vasculitis, vasculitis-induced thrombosis/occlusion, parenchymal ischemia/microinfarction, and parenchymal cell infection in the central nervous system (CNS), lung, kidney and other major organs. This unique dual pathogenetic mechanism of vasculitis-induced microinfarction and neuronal infection causes severe tissue damage in the CNS. Both viruses can also cause relapsing encephalitis months and years after the acute infection. Many animal models studied to date have largely confirmed the pathology of henipavirus infection, and provided the means to test new therapeutic agents and vaccines. As the bat is the natural host of henipaviruses and has worldwide distribution, spillover events into human populations are expected to occur in the future.

Keywords

References

  1. Patholog Res Int. 2011;2011:567248 [PMID: 21961078]
  2. Emerg Infect Dis. 2008 Dec;14(12):1974-6 [PMID: 19046545]
  3. J Virol. 2009 May;83(10):5148-55 [PMID: 19264786]
  4. AJR Am J Roentgenol. 2000 Aug;175(2):437-42 [PMID: 10915690]
  5. PLoS One. 2012;7(2):e32157 [PMID: 22393386]
  6. Emerg Infect Dis. 2009 Jun;15(6):950-2 [PMID: 19523300]
  7. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16508-13 [PMID: 17053073]
  8. Vet Microbiol. 1999 Aug 16;68(1-2):83-7 [PMID: 10501164]
  9. Emerg Infect Dis. 2001 Jul-Aug;7(4):759-61 [PMID: 11592256]
  10. Vet Pathol. 2015 Jan;52(1):38-45 [PMID: 25352203]
  11. Ann Neurol. 2002 Jun;51(6):703-8 [PMID: 12112075]
  12. Lancet Infect Dis. 2012 Oct;12(10):799-807 [PMID: 22921953]
  13. PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3302 [PMID: 25412358]
  14. Emerg Infect Dis. 2004 Dec;10(12):2082-7 [PMID: 15663842]
  15. J Virol Methods. 2004 Sep 15;120(2):229-37 [PMID: 15288966]
  16. PLoS Pathog. 2009 Oct;5(10):e1000642 [PMID: 19888339]
  17. Vaccine. 2011 Aug 5;29(34):5623-30 [PMID: 21689706]
  18. Can J Neurol Sci. 2002 Feb;29(1):83-7 [PMID: 11858542]
  19. Sci Transl Med. 2011 Oct 19;3(105):105ra103 [PMID: 22013123]
  20. Ann Neurol. 2007 Sep;62(3):235-42 [PMID: 17696217]
  21. Acta Neuropathol. 2010 Sep;120(3):317-25 [PMID: 20652579]
  22. Rev Med Virol. 2007 Mar-Apr;17(2):67-91 [PMID: 17042030]
  23. J Infect Dis. 2000 May;181(5):1760-3 [PMID: 10823780]
  24. Ann Neurol. 2001 Jun;49(6):810-3 [PMID: 11409437]
  25. Antiviral Res. 2013 Oct;100(1):8-13 [PMID: 23838047]
  26. Nature. 2005 Jul 21;436(7049):401-5 [PMID: 16007075]
  27. Southeast Asian J Trop Med Public Health. 2000 Jun;31(2):307-9 [PMID: 11127331]
  28. Arch Virol. 2005 Mar;150(3):521-32 [PMID: 15526144]
  29. Vaccine. 2015 Jun 4;33(24):2823-9 [PMID: 25865472]
  30. PLoS One. 2011 Apr 06;6(4):e18437 [PMID: 21494680]
  31. Med J Aust. 1995 Jun 19;162(12):642-5 [PMID: 7603375]
  32. J Infect. 2001 Jan;42(1):40-3 [PMID: 11243752]
  33. J Comp Pathol. 2007 May;136(4):266-72 [PMID: 17498518]
  34. Microbes Infect. 2002 Feb;4(2):145-51 [PMID: 11880045]
  35. AJNR Am J Neuroradiol. 2000 Mar;21(3):455-61 [PMID: 10730635]
  36. Lancet. 1997 Jan 11;349(9045):93-5 [PMID: 8996421]
  37. J Infect Dis. 2000 May;181(5):1755-9 [PMID: 10823779]
  38. PLoS One. 2011;6(9):e25275 [PMID: 21980413]
  39. Emerg Infect Dis. 2005 Jul;11(7):1042-7 [PMID: 16022778]
  40. J Virol Methods. 2009 Sep;160(1-2):1-6 [PMID: 19559943]
  41. Clin Microbiol Rev. 2006 Jul;19(3):531-45 [PMID: 16847084]
  42. Virol J. 2013 Dec 13;10:353 [PMID: 24330654]
  43. J Infect Dis. 2013 Feb 1;207(3):469-78 [PMID: 23175762]
  44. Emerg Infect Dis. 2007 Jan;13(1):159-61 [PMID: 17370536]
  45. J Neuropsychiatry Clin Neurosci. 2004 Fall;16(4):500-4 [PMID: 15616178]
  46. Am J Pathol. 2002 Dec;161(6):2153-67 [PMID: 12466131]
  47. J Comp Pathol. 2006 Aug-Oct;135(2-3):74-82 [PMID: 16956618]
  48. J Virol. 2006 Aug;80(16):7929-38 [PMID: 16873250]
  49. J Comp Pathol. 2000 Feb-Apr;122(2-3):201-7 [PMID: 10684689]
  50. Indian J Med Res. 2006 Apr;123(4):553-60 [PMID: 16783047]
  51. PLoS One. 2008 Jul 23;3(7):e2739 [PMID: 18648649]
  52. Sci Transl Med. 2014 Jun 25;6(242):242ra82 [PMID: 24964990]
  53. Emerg Infect Dis. 2010 Feb;16(2):219-23 [PMID: 20113550]
  54. Curr Top Microbiol Immunol. 2012;359:197-223 [PMID: 22481140]
  55. Microbes Infect. 2001 Apr;3(4):297-306 [PMID: 11334747]
  56. Emerg Infect Dis. 2005 Dec;11(12):1949-51 [PMID: 16485487]
  57. J Virol. 2006 Dec;80(24):12293-302 [PMID: 17005664]
  58. Neuropathol Appl Neurobiol. 2009 Jun;35(3):296-305 [PMID: 19473296]
  59. J Virol Methods. 2009 Oct;161(1):52-7 [PMID: 19477200]
  60. Sci Transl Med. 2012 Aug 8;4(146):146ra107 [PMID: 22875827]
  61. Antimicrob Agents Chemother. 2006 May;50(5):1768-72 [PMID: 16641448]
  62. Clin Infect Dis. 2009 Dec 1;49(11):1743-8 [PMID: 19886791]
  63. J Pathol. 2015 Jan;235(2):196-205 [PMID: 25229234]
  64. J Infect Dis. 2001 Nov 15;184(10):1367 [PMID: 11679933]
  65. Antiviral Res. 2014 Jan;101:26-9 [PMID: 24184127]
  66. J Comp Pathol. 2002 Feb-Apr;126(2-3):124-36 [PMID: 11945001]
  67. Emerg Infect Dis. 2005 Oct;11(10):1594-7 [PMID: 16318702]
  68. Emerg Infect Dis. 2001 May-Jun;7(3):439-41 [PMID: 11384522]
  69. Science. 2000 May 26;288(5470):1432-5 [PMID: 10827955]
  70. Curr Top Microbiol Immunol. 2012;359:153-77 [PMID: 22476556]
  71. Curr Top Microbiol Immunol. 2012;359:105-21 [PMID: 22476529]
  72. J Infect Dis. 2013 Jan 1;207(1):142-51 [PMID: 23089589]
  73. Emerg Infect Dis. 2014 Jun;20(6):1064-6 [PMID: 24865545]
  74. Int J Epidemiol. 2001 Oct;30(5):1017-20 [PMID: 11689513]
  75. PLoS One. 2012;7(7):e40308 [PMID: 22808132]
  76. Springer Semin Immunopathol. 2002;24(2):215-28 [PMID: 12503066]
  77. PLoS One. 2013;8(3):e58414 [PMID: 23516477]
  78. Emerg Infect Dis. 2002 Sep;8(9):987-8 [PMID: 12194780]
  79. J Virol Methods. 2012 Jan;179(1):226-32 [PMID: 22115786]
  80. J Virol. 2011 Aug;85(15):7658-71 [PMID: 21593160]
  81. Vet J. 2009 Sep;181(3):211-20 [PMID: 19084436]
  82. Med J Aust. 2006 Nov 20;185(10):562-4 [PMID: 17115969]
  83. Microbes Infect. 2001 Apr;3(4):315-22 [PMID: 11334749]
  84. PLoS Negl Trop Dis. 2013;7(1):e2024 [PMID: 23342177]
  85. J Virol. 2005 Jun;79(12):7528-34 [PMID: 15919907]
  86. Clin Infect Dis. 2008 Apr 1;46(7):977-84 [PMID: 18444812]
  87. Nat Commun. 2012 Apr 24;3:796 [PMID: 22531181]
  88. Vet Res. 2010 May-Jun;41(3):33 [PMID: 20167195]
  89. Virology. 2009 May 10;387(2):459-65 [PMID: 19328514]
  90. Virus Res. 2003 Mar;92(1):89-98 [PMID: 12606080]
  91. J Virol. 2004 Jan;78(2):834-40 [PMID: 14694115]
  92. J Virol. 2010 Oct;84(19):9831-9 [PMID: 20660198]
  93. Aust Vet J. 2012 Dec;90(12):N2 [PMID: 23186097]
  94. Neuropathol Appl Neurobiol. 2000 Aug;26(4):313-8 [PMID: 10931364]
  95. J Virol. 2006 Feb;80(4):1972-8 [PMID: 16439553]
  96. Emerg Infect Dis. 2008 Aug;14(8):1309-11 [PMID: 18680665]
  97. Curr Top Microbiol Immunol. 2012;359:95-104 [PMID: 22427144]
  98. Nat Commun. 2014 Nov 18;5:5342 [PMID: 25405640]
  99. J Virol. 2009 Nov;83(22):11979-82 [PMID: 19759137]
  100. Vet Pathol. 2008 Jul;45(4):576-85 [PMID: 18587107]
  101. Curr Opin Virol. 2013 Feb;3(1):84-91 [PMID: 23265969]
  102. Virus Res. 2008 Mar;132(1-2):140-4 [PMID: 18166242]
  103. Ann Neurol. 1999 Sep;46(3):428-32 [PMID: 10482278]
  104. N S W Public Health Bull. 2011 Jul;22(5-6):118-22 [PMID: 21781619]
  105. Curr Top Microbiol Immunol. 2012;359:179-96 [PMID: 22481141]
  106. Sci Rep. 2012;2:736 [PMID: 23071900]
  107. N Engl J Med. 2000 Apr 27;342(17):1229-35 [PMID: 10781618]
  108. J Neurol Neurosurg Psychiatry. 1972 Apr;35(2):180-5 [PMID: 4113955]
  109. Aust Vet J. 1998 Dec;76(12):813-8 [PMID: 9972433]
  110. PLoS One. 2013 Jul 22;8(7):e69544 [PMID: 23894501]
  111. J Virol. 2015 Jan;89(1):144-54 [PMID: 25320306]
  112. Lancet. 1999 Oct 9;354(9186):1253-6 [PMID: 10520634]
  113. Emerg Infect Dis. 2007 Jul;13(7):1031-7 [PMID: 18214175]
  114. Emerg Infect Dis. 2009 Aug;15(8):1229-35 [PMID: 19751584]
  115. Am J Pathol. 2003 Nov;163(5):2127-37 [PMID: 14578210]
  116. Ann Acad Med Singap. 2003 Jan;32(1):112-7 [PMID: 12625108]
  117. Emerg Infect Dis. 2015 Feb;21(2):328-31 [PMID: 25626011]
  118. Science. 1995 Apr 7;268(5207):94-7 [PMID: 7701348]
  119. Microbes Infect. 2001 Apr;3(4):279-87 [PMID: 11334745]
  120. Emerg Infect Dis. 2010 Mar;16(3):507-10 [PMID: 20202432]
  121. Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10652-7 [PMID: 15998730]
  122. Emerg Infect Dis. 2010 Dec;16(12):1990-3 [PMID: 21122240]
  123. J Gen Virol. 2010 Mar;91(Pt 3):765-72 [PMID: 19889926]
  124. PLoS One. 2010 May 18;5(5):e10690 [PMID: 20502528]
  125. PLoS Pathog. 2012;8(8):e1002836 [PMID: 22879820]
  126. Emerg Infect Dis. 2012 Dec;18(12):1983-93 [PMID: 23171621]
  127. Virology. 1989 Dec;173(2):415-25 [PMID: 2596022]
  128. MMWR Morb Mortal Wkly Rep. 1999 Apr 30;48(16):335-7 [PMID: 10366143]
  129. Curr Top Microbiol Immunol. 2012;359:59-78 [PMID: 22695915]
  130. J Gen Virol. 2000 Aug;81(Pt 8):1927-1932 [PMID: 10900029]
  131. J Infect Dis. 2001 Mar 1;183(5):810-3 [PMID: 11181159]

MeSH Term

Animals
Antiviral Agents
Brain
Encephalitis, Viral
Hendra Virus
Henipavirus Infections
Humans
Immunization, Passive
Nipah Virus

Chemicals

Antiviral Agents

Word Cloud

Created with Highcharts 10.0.0virusinfectionHenipavirusHendraHeVNipahNiVAustraliacausesevereoutbreakshumanshenipavirusessimilaracutepathologicalvasculitis-inducedparenchymalCNSencephalitisgenuswithinfamilyParamyxoviridaeincludesdiscovered1990sMalaysiarespectivelyemergingoftenfatalanimalsconfinedrecentreportedBangladeshIndiaPhilippinesclinicalmanifestationsappearpredominanceencephaliticsyndromeLikewisefeaturescharacterizeddisseminatedmulti-organvasculopathycomprisingendothelialinfection/ulcerationvasculitisthrombosis/occlusionischemia/microinfarctioncellcentralnervoussystemlungkidneymajororgansuniquedualpathogeneticmechanismmicroinfarctionneuronalcausestissuedamagevirusescanalsorelapsingmonthsyearsManyanimalmodelsstudieddatelargelyconfirmedpathologyhenipavirusprovidedmeanstestnewtherapeuticagentsvaccinesbatnaturalhostworldwidedistributionspillovereventshumanpopulationsexpectedoccurfutureEncephalitis:RecentDevelopmentsAdvances

Similar Articles

Cited By